DAIVONEX

This brand name is authorized in Brazil, Estonia, France, Hong Kong SAR China, Italy, Lithuania, Mexico, New Zealand, Singapore, Spain, Tunisia.

Active ingredients

The drug DAIVONEX contains one active pharmaceutical ingredient (API):

1	Calcipotriol UNII 143NQ3779B - CALCIPOTRIENE
	Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing.
	Read more about Calcipotriol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DAIVONEX Ointment	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D05AX02	Calcipotriol	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	541100301168316
EE	Ravimiamet	1007693, 1018549, 1147036, 1147047, 1794146
ES	Centro de información online de medicamentos de la AEMPS	60944
FR	Base de données publique des médicaments	62596393, 64016362
HK	Department of Health Drug Office	35877
IT	Agenzia del Farmaco	028253019, 028253021
LT	Valstybinė vaistų kontrolės tarnyba	1079984
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	358M95
NZ	Medicines and Medical Devices Safety Authority	6184
SG	Health Sciences Authority	06587P
TN	Direction de la Pharmacie et du Médicament	5823061, 5823063